Christopher P. Kerrigan

Christopher Kerrigan practices at Laboratory Services in Costa Mesa, California.

Christopher Kerrigan's NPI, 1508253634, was assigned on April 15, 2015. Christopher Kerrigan graduated from University of Medical Science Poznan in 2014. Christopher Kerrigan's California license number on file is A165043.

Christopher Kerrigan's primary practice is Laboratory Services, at 245 Fischer Ave, Costa Mesa, CA 92626 in Orange County. The practice phone is (657) 267-0063.

Christopher Kerrigan's primary practice is Laboratory Services in Costa Mesa, California. Christopher Kerrigan is also affiliated with Brigham and Women's Hospital. The medical group on file is Massachusetts General Physicians Organization (MGPO). Dmand AI also links Christopher Kerrigan to 3 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Christopher Kerrigan practices, 2 sites in all. Vendor and product names are available with a free account.

Addiction medicine is Christopher Kerrigan's primary specialty in the NPI Registry, under taxonomy code 207RA0401X. Christopher Kerrigan is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Christopher Kerrigan's licenses on file in 4 states: California, Tennessee, Montana and Wyoming.

Dmand AI lists alcohol use disorders, anxiety, atrial fibrillation and flutter, bipolar disorder, carpal tunnel syndrome, chronic kidney disease, chronic obstructive pulmonary disease (COPD) and depression among the conditions Christopher Kerrigan treats.

CMS data shows 91 Medicare services from Christopher Kerrigan across 2 procedure codes in 2024, all of them office visits, for 42 Medicare patients. Medicare paid $5,361 for them.

CMS counts 42 Medicare patients who saw Christopher Kerrigan in 2024. The largest group is 65 to 74, with 21 patients. 75% of them have alcohol and drug use disorders, and 75% have anxiety. 50% are also on Medicaid. Their average risk score is 1.84, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Christopher Kerrigan's median patient age at 47, with 32% women.

In 2024, Christopher Kerrigan wrote 376 Medicare Part D claims for 70 patients. 88% of them were for generic drugs. CMS names the drug for 214 of them, across 8 drugs with 11 or more claims each, at $54,780 in total drug cost. In 2023, CMS named 840 claims across 25 drugs.

Christopher Kerrigan accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 30 general payments to Christopher Kerrigan from 9 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 100% of the total. Gilead Sciences, Inc. paid the most, $340.

Christopher Kerrigan graduated from University of Medical Science Poznan in 2014.

Christopher Kerrigan is in network with 10 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.